Hear Dr Jessica Menis and Dr Benjamin Besse to talk to ecancertv at WIN 2015 about SPECTAlung.
Author Archives: admin
Blood-based biomarkers such as circulating tumor cells (CTCs), circulating free DNA (cfDNA), circulating tumor DNA (ctDNA) and microRNAs (miRNAs) are potential indicators for the tumor burden of patients living with cancer. Identification and analysis of these markers from blood is still exploratory, but they may offer an additional and extremely useful tool for modern
The second edition of SPECTAforum met its objectives with representation of most of the stakeholders. With SPECTAcolor, the first platform, now rapidly reaching over 200 patients, SPECTA, an innovative approach to efficient access to molecular target-based clinical trials, has demonstrated international feasibility. Routes for stakeholders to join SPECTA are now being launched. Additional disease-oriented platforms